1,10-phenanthroline has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czupryn, M | 1 |
| Brown, WE | 1 |
| Vallee, BL | 1 |
| Kamath, NS | 1 |
| Satyamoorthy, K | 1 |
| Chitnis, MP | 1 |
| Advani, SH | 1 |
2 other studies available for 1,10-phenanthroline and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Zinc rapidly induces a metal response element-binding factor.
Topics: Base Sequence; Carcinoma, Hepatocellular; Cell Nucleus; DNA Probes; DNA-Binding Proteins; Edetic Aci | 1992 |
1,10-phenanthroline potentiates cytotoxicity of hydroxyurea in human chronic myeloid leukemia cells.
Topics: DNA; Drug Synergism; Humans; Hydroxyurea; Iron; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Le | 1989 |